Amgen Inc (AMGN)
306.95
+1.18
(+0.39%)
USD |
NASDAQ |
Mar 28, 16:00
306.00
-0.95
(-0.31%)
After-Hours: 20:00
Amgen Market Cap: 164.90B for March 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Gilead Sciences Inc | 139.22B |
Johnson & Johnson | 394.52B |
Eli Lilly and Co | 738.75B |
Regeneron Pharmaceuticals Inc | 69.68B |
Viking Therapeutics Inc | 2.879B |
Market Cap Related Metrics
PE Ratio | 40.66 |
PS Ratio | 4.959 |
Price to Book Value | 28.06 |
Price to Free Cash Flow | 15.95 |
Price | 306.95 |
Earnings Yield | 2.46% |
Operating PE Ratio | 22.84 |
Normalized PE Ratio | 40.66 |